Compare PRAX & SSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRAX | SSB |
|---|---|---|
| Founded | 2015 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 9.4B |
| IPO Year | 2020 | 2008 |
| Metric | PRAX | SSB |
|---|---|---|
| Price | $250.33 | $95.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $572.13 | $118.00 |
| AVG Volume (30 Days) | 439.6K | ★ 577.7K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | N/A | ★ 12.91 |
| EPS | N/A | ★ 2.28 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.07 |
| Revenue Next Year | $7,758.26 | $6.51 |
| P/E Ratio | ★ N/A | $41.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.25 | $84.48 |
| 52 Week High | $366.52 | $108.46 |
| Indicator | PRAX | SSB |
|---|---|---|
| Relative Strength Index (RSI) | 30.44 | 52.44 |
| Support Level | $157.29 | $92.40 |
| Resistance Level | $342.62 | $96.13 |
| Average True Range (ATR) | 21.30 | 1.74 |
| MACD | -10.67 | 0.23 |
| Stochastic Oscillator | 4.85 | 58.83 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.